[EN] PYRROLOTHIAZOLES AS PI3-KINASE INHIBITORS<br/>[FR] PYRROLOTHIAZOLES COMME INHIBITEURS DE LA PI3 KINASE
申请人:UCB PHARMA SA
公开号:WO2009071888A1
公开(公告)日:2009-06-11
A series of 4,5-dihydro-6H-pyrrolo[3,4-d][1,3]thiazol-6-one derivatives, and analogues thereof, which are substituted in the 2-position by an optionally substituted morpholin-4-yl moiety, being selective inhibitors of PI3 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions.
一系列在2-位置被一个可选择取代的吗啡啶-4-基团取代的4,5-二氢-6H-吡咯并[3,4-d][1,3]噻唑-6-酮衍生物及其类似物,是选择性PI3激酶酶抑制剂,在医学上具有益处,例如在治疗炎症、自身免疫、心血管、神经退行性、代谢、肿瘤、疼痛或眼科疾病方面。